Polyvinylpyrrolidone Nanofibers Incorporating Mesoporous Bioactive Glass for Bone Tissue Engineering

Recent Advances and Challenges for Biological Materials in Micro/Nanocarrier Synthesis for Bone Infection and Tissue Engineering

Roughly 1.71 billion people worldwide suffer from large bone abnormalities, which are the primary cause of disability. Traditional bone grafting procedures have several drawbacks that impair their therapeutic efficacy and restrict their use in clinical settings. A great deal of work has been done to create fresh, more potent strategies. Under these circumstances, a crucial technique for the regeneration of major lesions has emerged: bone tissue engineering (BTE). BTE involves the use of biomaterials that can imitate the natural design of bone. To yet, no biological material has been able to fully meet the parameters of the perfect implantable material, even though several varieties have been created and investigated for bone regeneration. Against this backdrop, researchers have focused a great deal of interest over the past few years on the subject of nanotechnology and the use of nanostructures in regenerative medicine. The ability to create nanoengineered particles that can overcome the current constraints in regenerative strategies─such as decreased cell proliferation and differentiation, insufficient mechanical strength in biological materials, and insufficient production of extrinsic factors required for effective osteogenesis has revolutionized the field of bone and tissue engineering. The effects of nanoparticles on cell characteristics and the application of biological materials for bone regeneration are the main topics of our review, which summarizes the most recent in vitro and in vivo research on the application of nanotechnology in the context of BTE.

Incorporation of forsterite nanoparticles in a 3D printed polylactic acid/polyvinylpyrrolidone scaffold for bone tissue regeneration applications

Three-dimensional (3D) printing has facilitated the fabrication of customized scaffolds for the repair of complex bone defects. In this study, 3D-printed scaffolds composed of a mixture of polylactic acid-polyvinylpyrrolidone (PLA-PVP) incorporating different amounts of forsterite (F; Mg2SiO4) nanoparticles were fabricated using fused deposition modeling (FDM) technique. The incorporation of PVP and F nanoparticles into the PLA scaffold significantly decreased the water drop contact angle. The mechanical properties of the PLA-PVP scaffold were enhanced with the addition of 10 % F nanoparticles, as the compressive yield strength increased from 10.8 to 16.0 MPa and the elastic modulus from 83.52 to 108.41 MPa. However, the addition of F nanoparticles increased the degradation rate of the PLA-PVP scaffold over 8 weeks. Importantly, the addition of 10 % F nanoparticles into the PLA-PVP scaffold improved bioactivity and formation of apatite deposits on the scaffold after 4 weeks of immersion in simulated body fluid. Moreover, the PLA-PVP/10F scaffold showed strong MG63 cell adhesion and proliferation, as well as promoting osteogenic differentiation of rat bone marrow mesenchymal stem cells. At last, these findings suggest the PLA-PVP/10F scaffold is a promising candidate for application in bone defect repair.

Enhancing orthopaedic implant efficacy: the development of cerium-doped bioactive glass and polyvinylpyrrolidone composite coatings via MAPLE technique

This study investigates the potential of combining Cerium-doped bioactive glass (BBGi) with Polyvinylpyrrolidone (PVP) to enhance the properties of titanium (Ti) implant surfaces using the Matrix-Assisted Pulsed Laser Evaporation (MAPLE) technique. The primary focus is on improving osseointegration, corrosion resistance, and evaluating the cytotoxicity of the developed thin films towards host cells. The innovative approach involves synthesizing a composite thin film comprising BBGi and PVP, leveraging the distinct benefits of both materials: BBGi's biocompatibility and osteoinductive capabilities, and PVP's film-forming and biocompatible properties. Results demonstrate that the BBGi + PVP coatings significantly enhance hydrophilicity, indicating improved cell-material interaction potential. The electrochemical analysis reveals superior corrosion resistance of the BBGi + PVP films compared to BBGi alone, which is critical for long-term implant stability. The mechanical adherence tests confirm the robust attachment of the coatings to Ti substrates, surpassing the ISO standards for implant materials. Biocompatibility tests show promising cell viability and negligible cytotoxic effects, with a controlled inflammatory response, underscoring the potential of BBGi + PVP coatings for orthopedic applications. The study concludes that the synergistic combination of BBGi and PVP, applied through the MAPLE technique, offers a promising route to fabricate bioactive and corrosion-resistant coatings for Ti implants, potentially enhancing osseointegration and longevity in clinical settings.

Incorporating bioactive glass nanoparticles in silk fibroin/bacterial nanocellulose composite scaffolds improves their biological and osteogenic properties for bone tissue engineering applications

Blend polymers composed of natural polymers are a ubiquitous biomaterial class due to their suitable mechanical and biological characterization. In the present study, composite scaffolds based on bacterial cellulose (BC)/silk fibroin (SF) with bioactive glass nanoparticles (BGNPs) were developed to enhance osteogenesis in human adipose derived stem cells (hASCs). The scanning electron microscopy (SEM) results of BGNPs indicated a spherical morphology and size ranging from 15 to 30 nm. The presence of BC and BGNPs reduced the pore diameter of SF scaffolds to about 210 ± 10 μm and 205 ± 10 μm, respectively, while increasing their compressive strength and compressive modulus. FTIR analyses proved the presence of BGNPs, BC and SF in the scaffolds. Flow cytometry data confirmed the surface markers for hASCs. The results also showed that BC and BGNPs addition to BC/SF scaffolds decreased degradation and swelling rate. The gene expression (Runx2, alkaline phosphatase and osteocalcin) studies signified the osteogenic potential of BGNPs in BC/SF scaffolds on hASCs. Eventually, the increased cell adhesion, viability and differentiation in the BC/SF and BC/SF/BGNPs composite scaffolds drawn from MTT, SEM, Alizarin red staining and alkaline phosphatase activity confirmed that these scaffolds promise to serve as a therapeutic candidate for bone defects.